Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.26 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (parietal cells) | 0.10 |
| chemistry Open Targets | compounds already reach it: esomeprazole strontium, omeprazole, omeprazole magnesium +14 | 1.00 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 1 stopped | 0.60 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly other | 0.30 |
No case: the score is under the bar. Receipt 1628
Sealed predictions
- ATP4A in dopamine neurons, braak-0.45 (p 0.222) → +0.09 (p 0.825)receipt 1635
Swarm cases
receipt 1635: ATP4A in dopamine neurons, braak
- power
- full sample -0.29 (p 0.239, n 18), 95% CI -0.67 to +0.20. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.37 (p 0.130, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.53 (p 0.024, n 18). not the mix.
- skeptic
- leave-one-out range -0.45 to -0.21, sign flips 0; without severely affected donors -0.29 (p 0.239, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ATP4A in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts